Ceva Animal Health extends its anti-parasitic range with the launch of DUOFLECT
Ceva Animal Health has extended its companion animal anti-parasitic range with the launch of DUOFLECT, a new strength formulation for the treatment and prevention of flea and tick infestations in both cats and dogs and also the environment.
Containing a new strength formulation of the tried and trusted active ingredients, fipronil and (s)-methoprene, DUOFLECT’s duration of action against fleas is 100% longer in cats (eight weeks) and 13% longer in dogs (nine weeks) than the market-leading fipronil combination,while its duration of action against ticks is 150% longer in cats (five weeks) and 50% longer in dogs (six weeks). It acts against both adult fleas on the animal and immature flea stages in the environment and it can also be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
DUOFLECT is available in unique, new, easy-to-use, free-standing pipettes for easier administration and handling of the pet, ensuring no spillages which aids owner compliance. The pipettes are packed in child resistant aluminium blisters to reduce the risk of accidents at home.
“Recent research has revealed that two main factors in prescribing parasitic control products are the length of action and the increased efficacy against fleas,” comments Nicki Glen, marketing project manager for DUOFLECT at Ceva Animal Health. “DUOFLECT’s new strength formulation provides a longer duration of action than the market-leading fipronil combination, while its efficacy is proven through 13 recent laboratory and field trials.”
DUOFLECT is competitively priced and is available in boxes of three or six pipettes and in five presentations: small cats (1-5kg), large cats (>5kg) and small dogs (2-10kg) and medium dogs (10-20kg), large dogs (20-40kg) and extra large dogs (40-60kg). It is suitable for cats and dogs from eight weeks of age.